BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18971896)

  • 1. [Low-dose flutamide in the treatment of hyperandrogenism in adolescents].
    Pizzo A; Borrielli I; Mastroeni MT; Fattori A; Dugo C; Dugo N; Dinatale A
    Minerva Pediatr; 2008 Dec; 60(6):1357-66. PubMed ID: 18971896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.
    Ibáñez L; Jaramillo A; Ferrer A; de Zegher F
    Hum Reprod; 2005 Jul; 20(7):1833-6. PubMed ID: 15802316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very low dose of flutamide in the treatment of hyperandrogenism.
    Fulghesu AM; Melis F; Murru G; Canu E; Melis GB
    Gynecol Endocrinol; 2018 May; 34(5):394-398. PubMed ID: 29108453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
    Ibáñez L; de Zegher F
    Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Finasteride and flutamide in the treatment of hirsutism].
    Falsetti L; De Fusco D; Rosina B
    Minerva Ginecol; 1997 Oct; 49(10):463-8. PubMed ID: 9463180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
    Ibáñez L; de Zegher F
    Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and tolerability of flutamide for the treatment of hirsutism.
    Castelo-Branco C; Moyano D; Gómez O; Balasch J
    Fertil Steril; 2009 Apr; 91(4):1183-8. PubMed ID: 18339379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term, low-dose flutamide does not cause hepatotoxicity in hyperandrogenic women.
    Legro RS
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):188-9. PubMed ID: 16932279
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antiandrogens as therapy for women with polycystic ovary syndrome.
    Moghetti P
    Fertil Steril; 2006 Jul; 86 Suppl 1():S30-1. PubMed ID: 16798285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
    Ibáñez L; De Zegher F
    Hum Reprod; 2004 Aug; 19(8):1725-7. PubMed ID: 15229206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.
    Ibáñez L; Jaramillo AM; Ferrer A; de Zegher F
    Hum Reprod; 2005 Sep; 20(9):2457-62. PubMed ID: 15905296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial.
    Calaf J; López E; Millet A; Alcañiz J; Fortuny A; Vidal O; Callejo J; Escobar-Jiménez F; Torres E; Espinós JJ;
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3446-52. PubMed ID: 17566093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.
    Ibáñez L; Potau N; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3251-5. PubMed ID: 10999817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
    Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal therapy for acne: why not as first line therapy? facts and controversies.
    Katsambas AD; Dessinioti C
    Clin Dermatol; 2010; 28(1):17-23. PubMed ID: 20082945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of yasmin in the treatment of women with polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M; Ivancheva Kh; Amaliev I
    Akush Ginekol (Sofiia); 2006; 45(3):25-9. PubMed ID: 16889184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirsutism and acne in polycystic ovary syndrome.
    Archer JS; Chang RJ
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):737-54. PubMed ID: 15380144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.
    Boztosun A; Açmaz G; Ozturk A; Müderris II
    Ginekol Pol; 2013 Apr; 84(4):258-62. PubMed ID: 23700857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
    Ibáñez L; De Zegher F
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4720-4. PubMed ID: 14557446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.